Growth Metrics

Standard Biotools (LAB) Free Cash Flow (2016 - 2026)

Standard Biotools has reported Free Cash Flow over the past 16 years, most recently at -$9.4 million for Q4 2025.

  • Quarterly Free Cash Flow rose 14.15% to -$9.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$82.6 million through Dec 2025, up 43.11% year-over-year, with the annual reading at -$82.6 million for FY2025, 43.11% up from the prior year.
  • Free Cash Flow was -$9.4 million for Q4 2025 at Standard Biotools, up from -$15.4 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$500000.0 in Q4 2021 and troughed at -$63.3 million in Q1 2024.
  • The 5-year median for Free Cash Flow is -$19.9 million (2021), against an average of -$23.7 million.
  • Year-over-year, Free Cash Flow soared 96.54% in 2021 and then tumbled 3887.2% in 2022.
  • A 5-year view of Free Cash Flow shows it stood at -$500000.0 in 2021, then tumbled by 3887.2% to -$19.9 million in 2022, then soared by 43.28% to -$11.3 million in 2023, then rose by 3.61% to -$10.9 million in 2024, then increased by 14.15% to -$9.4 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Free Cash Flow are -$9.4 million (Q4 2025), -$15.4 million (Q3 2025), and -$22.6 million (Q2 2025).